|
Items
|
Tumor CCT6A expression
|
P value
|
|---|
|
Low (n = 200)
|
High (n = 181)
|
|---|
|
Age, No. (%)
| | |
0.239
|
|
≤60.0 years
|
106 (53.0)
|
85 (47.0)
| |
|
>60.0 years
|
94 (47.0)
|
96 (53.0)
| |
|
Gender, No. (%)
| | |
0.458
|
|
Female
|
53 (26.5)
|
42 (23.2)
| |
|
Male
|
147 (73.5)
|
139 (76.8)
| |
|
History of smoke, No. (%)
| | |
0.107
|
|
No
|
83 (41.5)
|
90 (49.7)
| |
|
Yes
|
117 (58.5)
|
91 (50.3)
| |
|
History of drink, No. (%)
| | |
0.565
|
|
No
|
124 (62.0)
|
107 (59.1)
| |
|
Yes
|
76 (38.0)
|
74 (40.9)
| |
|
Hypertension, No. (%)
| | |
0.774
|
|
No
|
122 (61.0)
|
113 (62.4)
| |
|
Yes
|
78 (39.0)
|
68 (37.6)
| |
|
Hyperlipidemia, No. (%)
| | |
0.824
|
|
No
|
136 (68.0)
|
125 (69.1)
| |
|
Yes
|
64 (32.0)
|
56 (30.9)
| |
|
Diabetes, No. (%)
| | |
0.479
|
|
No
|
170 (85.0)
|
149 (82.3)
| |
|
Yes
|
30 (15.0)
|
32 (17.7)
| |
|
Differentiation, No. (%)
| | |
0.627
|
|
Well
|
35 (17.5)
|
21 (11.6)
| |
|
Moderate
|
112 (56.0)
|
116 (64.1)
| |
|
Poor
|
53 (26.5)
|
44 (24.3)
| |
|
Tumor size, No. (%)
| | |
0.106
|
|
≤5.0 cm
|
130 (65.0)
|
103 (56.9)
| |
|
>5.0 cm
|
70 (35.0)
|
78 (43.1)
| |
|
LYN metastasis, No. (%)
| | |
0.001
|
|
No
|
145 (72.5)
|
102 (56.4)
| |
|
Yes
|
55 (27.5)
|
79 (43.6)
| |
|
TNM stage, No. (%)
| | |
0.002
|
|
I
|
82 (41.0)
|
49 (27.1)
| |
|
II
|
55 (27.5)
|
52 (28.7)
| |
|
III
|
63 (31.5)
|
80 (44.2)
| |
|
CEA, No. (%)
| | |
0.022
|
|
Normal (≤5.0 ng/mL)
|
95 (47.5)
|
65 (35.9)
| |
|
Abnormal (>5.0 ng/mL)
|
105 (52.5)
|
116 (64.1)
| |
- Comparison was determined by chi-square test or Wilcoxon rank-sum test. CCT6A chaperonin containing TCP1 subunit 6A; LYN lymph node; CEA carcinoembryonic antigen
